While EIF4EBP1 was characterized as a gene upregulated in MYCN-amplified versus MYCN-non-amplified NB tissues and cells [22], another study reported that EIF4EBP1 levels were higher in favorable stages of NB as compared to advanced stage 4 tumors [34]. This evidence concerns the gene MYCN and neuroblastoma.